{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T20:45:24Z","timestamp":1790196324937,"version":"4.1.0"},"reference-count":82,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Best Practice & Research Clinical Rheumatology"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.berh.2026.102129","type":"journal-article","created":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T13:11:39Z","timestamp":1773407499000},"page":"102129","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["The promise of biomarkers in Psoriatic Arthritis: Moving towards precision medicine"],"prefix":"10.1016","volume":"40","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7695-9977","authenticated-orcid":false,"given":"Myroslava","family":"Kulyk","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3848-5122","authenticated-orcid":false,"given":"Kurt","family":"De Vlam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.berh.2026.102129_bib1","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.semarthrit.2018.01.003","article-title":"Prevalence and incidence of psoriatic arthritis: a systematic review and meta-analysis","volume":"48","author":"Scotti","year":"2018","journal-title":"Semin Arthritis Rheum"},{"issue":"1","key":"10.1016\/j.berh.2026.102129_bib2","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.jaad.2018.06.027","article-title":"Prevalence of psoriatic arthritis in patients with psoriasis: a systematic review and meta-analysis of observational and clinical studies","volume":"80","author":"Alinaghi","year":"2019","journal-title":"J Am Acad Dermatol"},{"issue":"10","key":"10.1016\/j.berh.2026.102129_bib3","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1056\/NEJMra1505557","article-title":"Psoriatic Arthritis","volume":"376","author":"Ritchlin","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.berh.2026.102129_bib4","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.jaut.2016.10.009","article-title":"Management of psoriatic arthritis: early diagnosis, monitoring of disease severity and cutting edge therapies","volume":"76","author":"Raychaudhuri","year":"2017","journal-title":"J Autoimmun"},{"issue":"11","key":"10.1016\/j.berh.2026.102129_bib5","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1136\/annrheumdis-2021-220263","article-title":"Effectiveness of IL-12\/23 inhibition (ustekinumab) versus tumour necrosis factor inhibition in psoriatic arthritis: observational PsABio study results","volume":"80","author":"Smolen","year":"2021","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"10.1016\/j.berh.2026.102129_bib6","doi-asserted-by":"crossref","first-page":"rky042","DOI":"10.1093\/rap\/rky042","article-title":"Long-term effectiveness of tumour necrosis factor-alpha inhibitor treatment for psoriatic arthritis in the UK: a multicentre retrospective study","volume":"2","author":"Clunie","year":"2018","journal-title":"Rheumatol Adv Pract"},{"issue":"1","key":"10.1016\/j.berh.2026.102129_bib7","doi-asserted-by":"crossref","DOI":"10.3390\/proteomes6010005","article-title":"Exploring the psoriatic arthritis proteome in search of novel biomarkers","volume":"6","author":"Mahendran","year":"2018","journal-title":"Proteomes"},{"key":"10.1016\/j.berh.2026.102129_bib8","article-title":"Extra-Articular manifestations and comorbidities in psoriatic disease: a journey into the Immunologic crosstalk","volume":"8","author":"Novelli","year":"2021","journal-title":"Front Med (Lausanne)"},{"issue":"11","key":"10.1016\/j.berh.2026.102129_bib9","first-page":"1984","article-title":"Harnessing extracellular vesicles for biomarker discovery in psoriatic disease","volume":"43","author":"Bryan","year":"2025","journal-title":"Clin Exp Rheumatol"},{"issue":"3","key":"10.1016\/j.berh.2026.102129_bib10","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1038\/s41584-022-00874-5","article-title":"Phenotypic heterogeneity in psoriatic arthritis: towards tissue pathology-based therapy","volume":"19","author":"Najm","year":"2023","journal-title":"Nat Rev Rheumatol"},{"issue":"8","key":"10.1016\/j.berh.2026.102129_bib11","doi-asserted-by":"crossref","DOI":"10.3390\/metabo13080963","article-title":"A solid-phase microextraction-liquid chromatography-mass spectrometry method for analyzing serum lipids in psoriatic disease","volume":"13","author":"Koussiouris","year":"2023","journal-title":"Metabolites"},{"issue":"2","key":"10.1016\/j.berh.2026.102129_bib12","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.jdermsci.2021.03.006","article-title":"Large-scale plasma-metabolome analysis identifies potential biomarkers of psoriasis and its clinical subtypes","volume":"102","author":"Kishikawa","year":"2021","journal-title":"J Dermatol Sci"},{"issue":"10","key":"10.1016\/j.berh.2026.102129_bib13","doi-asserted-by":"crossref","DOI":"10.3390\/cells7100159","article-title":"Pathophysiological alterations of Redox signaling and endocannabinoid System in granulocytes and plasma of psoriatic patients","volume":"7","author":"Ambrozewicz","year":"2018","journal-title":"Cells"},{"issue":"1","key":"10.1016\/j.berh.2026.102129_bib14","doi-asserted-by":"crossref","DOI":"10.1136\/rmdopen-2024-005174","article-title":"Low apolipoprotein A1 and high apolipoprotein B levels indicate specific lipid changes in treatment naive early psoriatic arthritis","volume":"11","author":"Ishchenko","year":"2025","journal-title":"RMD Open"},{"issue":"1","key":"10.1016\/j.berh.2026.102129_bib15","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1186\/s13075-025-03608-6","article-title":"Investigation of serum biomarkers in rheumatoid and psoriatic arthritis patients for disease-specific signatures","volume":"27","author":"Veale","year":"2025","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.berh.2026.102129_bib16","article-title":"Plasma proteins and psoriatic arthritis: a proteome-wide Mendelian randomization study","volume":"15","author":"Zhao","year":"2024","journal-title":"Front Immunol"},{"key":"10.1016\/j.berh.2026.102129_bib17","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2024.1342172","article-title":"Investigating causal associations among gut microbiota, metabolites, and psoriatic arthritis: a Mendelian randomization study","volume":"15","author":"Xu","year":"2024","journal-title":"Front Microbiol"},{"issue":"1","key":"10.1016\/j.berh.2026.102129_bib18","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1186\/s41927-025-00511-0","article-title":"A six-month weight loss intervention is associated with significant changes in serum biomarkers related to inflammation, bone and cartilage metabolism in obese patients with psoriatic arthritis and matched controls","volume":"9","author":"Torres","year":"2025","journal-title":"BMC Rheumatol"},{"key":"10.1016\/j.berh.2026.102129_bib19","article-title":"Dual-platform urinary metabolomics identifies candidate diagnostic biomarkers in Psoriatic Arthritis","volume":"44","author":"Peddi","year":"2025","journal-title":"Biochem Biophys Rep"},{"issue":"7","key":"10.1016\/j.berh.2026.102129_bib20","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1002\/art.41652","article-title":"Tissue-Resident memory CD8+ T cells from skin differentiate psoriatic arthritis from psoriasis","volume":"73","author":"Leijten","year":"2021","journal-title":"Arthritis Rheumatol"},{"issue":"10","key":"10.1016\/j.berh.2026.102129_bib21","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1136\/annrheumdis-2022-222229","article-title":"Keratinocyte-derived S100A9 modulates neutrophil infiltration and affects psoriasis-like skin and joint disease","volume":"81","author":"Mellor","year":"2022","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.berh.2026.102129_bib22","article-title":"CD209\/CD14(+) dendritic cells characterization in rheumatoid and psoriatic arthritis patients: activation, synovial infiltration, and therapeutic targeting","volume":"12","author":"Marzaioli","year":"2021","journal-title":"Front Immunol"},{"issue":"3","key":"10.1016\/j.berh.2026.102129_bib23","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1002\/art.41156","article-title":"Polyfunctional, proinflammatory, tissue-resident memory phenotype and function of Synovial Interleukin-17A+CD8+ T cells in psoriatic arthritis","volume":"72","author":"Steel","year":"2020","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.berh.2026.102129_bib24","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2025.1483393","article-title":"Single-cell RNA sequencing of circulating immune cells supports inhibition of TNFAIP3 and NFKBIA translation as psoriatic arthritis biomarkers","volume":"16","author":"Garrido","year":"2025","journal-title":"Front Immunol"},{"issue":"20","key":"10.1016\/j.berh.2026.102129_bib25","doi-asserted-by":"crossref","DOI":"10.3390\/ijms222010990","article-title":"Blood-Based immune profiling combined with machine learning discriminates psoriatic arthritis from psoriasis patients","volume":"22","author":"Mulder","year":"2021","journal-title":"Int J Mol Sci"},{"issue":"2","key":"10.1016\/j.berh.2026.102129_bib26","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1097\/CM9.0000000000003288","article-title":"Differential expression of plasma extracellular vesicle miRNAs as biomarkers for distinguishing psoriatic arthritis from psoriasis","volume":"138","author":"Yan","year":"2025","journal-title":"Chin Med J (Engl)"},{"issue":"5","key":"10.1016\/j.berh.2026.102129_bib27","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2023.112514","article-title":"Psoriatic and rheumatoid arthritis joints differ in the composition of CD8+ tissue-resident memory T cell subsets","volume":"42","author":"Povoleri","year":"2023","journal-title":"Cell Rep"},{"issue":"1","key":"10.1016\/j.berh.2026.102129_bib28","doi-asserted-by":"crossref","first-page":"4767","DOI":"10.1038\/s41467-020-18513-6","article-title":"Single-cell sequencing reveals clonal expansions of pro-inflammatory synovial CD8 T cells expressing tissue-homing receptors in psoriatic arthritis","volume":"11","author":"Penkava","year":"2020","journal-title":"Nat Commun"},{"issue":"6","key":"10.1016\/j.berh.2026.102129_bib29","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1016\/j.jid.2024.08.039","article-title":"Imaging mass cytometry in psoriatic disease reveals immune profile heterogeneity in skin and synovial tissue","volume":"145","author":"Eder","year":"2025","journal-title":"J Invest Dermatol"},{"issue":"1","key":"10.1016\/j.berh.2026.102129_bib30","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2024.108059","article-title":"Deep phenotyping of T regulatory cells in psoriatic arthritis highlights targetable mechanisms of disease","volume":"301","author":"McTaggart","year":"2025","journal-title":"J Biol Chem"},{"key":"10.1016\/j.berh.2026.102129_bib31","doi-asserted-by":"crossref","DOI":"10.1155\/2024\/9927964","article-title":"Circulating immune landscape profiling in psoriasis vulgaris and psoriatic arthritis by mass cytometry","volume":"2024","author":"Sang","year":"2024","journal-title":"J Immunol Res"},{"issue":"1","key":"10.1016\/j.berh.2026.102129_bib32","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/s13075-023-03255-9","article-title":"Synovial tissue features associated with poor prognosis in inflammatory arthritis","volume":"26","author":"Azuaga","year":"2024","journal-title":"Arthritis Res Ther"},{"issue":"9","key":"10.1016\/j.berh.2026.102129_bib33","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1136\/annrheumdis-2021-221761","article-title":"Distinct stromal and immune cell interactions shape the pathogenesis of rheumatoid and psoriatic arthritis","volume":"81","author":"Floudas","year":"2022","journal-title":"Ann Rheum Dis"},{"issue":"15","key":"10.1016\/j.berh.2026.102129_bib34","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.178213","article-title":"Psoriatic arthritis subtypes are phenocopied in humanized mice","volume":"9","author":"Ritchlin","year":"2024","journal-title":"JCI Insight"},{"issue":"1","key":"10.1016\/j.berh.2026.102129_bib35","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1186\/s12891-023-06339-4","article-title":"Increased synovial immunohistochemistry reactivity of TGF-beta1 in erosive peripheral psoriatic arthritis","volume":"24","author":"Pinto Tasende","year":"2023","journal-title":"BMC Muscoskelet Disord"},{"key":"10.1016\/j.berh.2026.102129_bib36","doi-asserted-by":"crossref","first-page":"1936","DOI":"10.3389\/fimmu.2018.01936","article-title":"Anti-LL37 antibodies are present in psoriatic arthritis (PsA) patients: new biomarkers in PsA","volume":"9","author":"Frasca","year":"2018","journal-title":"Front Immunol"},{"issue":"7","key":"10.1016\/j.berh.2026.102129_bib37","doi-asserted-by":"crossref","DOI":"10.1002\/acr2.70014","article-title":"Identification of miR-190a-5p and miR-26b-5p as potential microRNA biomarkers for psoriatic arthritis","volume":"7","author":"Cruz-Correa","year":"2025","journal-title":"ACR Open Rheumatol"},{"issue":"1","key":"10.1016\/j.berh.2026.102129_bib38","doi-asserted-by":"crossref","DOI":"10.1002\/iid3.70128","article-title":"Comparative analysis of CXCR5 circulating DNA methylation levels in autoimmune rheumatic diseases","volume":"13","author":"Shi","year":"2025","journal-title":"Immun Inflamm Dis"},{"issue":"11","key":"10.1016\/j.berh.2026.102129_bib39","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0313344","article-title":"The shared biomarkers and immune landscape in psoriatic arthritis and rheumatoid arthritis: findings based on bioinformatics, machine learning and single-cell analysis","volume":"19","author":"Zhou","year":"2024","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.berh.2026.102129_bib40","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1007\/s10067-025-07374-3","article-title":"Role of miRNAs in the pathogenesis of psoriasis and psoriatic arthritis: a genome-wide Mendelian randomization study","volume":"44","author":"Li","year":"2025","journal-title":"Clin Rheumatol"},{"issue":"11","key":"10.1016\/j.berh.2026.102129_bib41","doi-asserted-by":"crossref","first-page":"5911","DOI":"10.1093\/rheumatology\/keaf311","article-title":"Sex differences in serum proteomic profiles in psoriatic arthritis","volume":"64","author":"Dang","year":"2025","journal-title":"Rheumatology (Oxford)"},{"issue":"1","key":"10.1016\/j.berh.2026.102129_bib42","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-021-00854-x","article-title":"Application of information theoretic feature selection and machine learning methods for the development of genetic risk prediction models","volume":"11","author":"Jalali-Najafabadi","year":"2021","journal-title":"Sci Rep"},{"issue":"9","key":"10.1016\/j.berh.2026.102129_bib43","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1002\/art.42154","article-title":"Comparative genetic analysis of psoriatic arthritis and psoriasis for the discovery of genetic risk factors and risk prediction modeling","volume":"74","author":"Soomro","year":"2022","journal-title":"Arthritis Rheumatol"},{"issue":"1","key":"10.1016\/j.berh.2026.102129_bib44","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1038\/s42003-025-07698-5","article-title":"An integrated multi-omics analysis identifies protein biomarkers and potential drug targets for psoriatic arthritis","volume":"8","author":"Cai","year":"2025","journal-title":"Commun Biol"},{"key":"10.1016\/j.berh.2026.102129_bib45","doi-asserted-by":"crossref","DOI":"10.1177\/24755303251344134","article-title":"Combining clinical, genetic and protein markers using machine learning models discriminates psoriatic arthritis patients from those with psoriasis","author":"Ganatra","year":"2025","journal-title":"J Psoriasis Psoriatic Arthritis"},{"issue":"1","key":"10.1016\/j.berh.2026.102129_bib46","doi-asserted-by":"crossref","DOI":"10.1136\/rmdopen-2022-002934","article-title":"Identification of PsA phenotypes with machine learning analytics using data from two phase III clinical trials of guselkumab in a bio-naive population of patients with PsA","volume":"9","author":"Richette","year":"2023","journal-title":"RMD Open"},{"issue":"4","key":"10.1016\/j.berh.2026.102129_bib47","doi-asserted-by":"crossref","DOI":"10.1136\/rmdopen-2024-004457","article-title":"Characterisation of myeloid cells in circulation and synovial fluid of patients with psoriatic arthritis","volume":"10","author":"Fine","year":"2024","journal-title":"RMD Open"},{"key":"10.1016\/j.berh.2026.102129_bib48","article-title":"Precision medicine based on the phenotypic differences in peripheral T helper cells in patients with psoriatic arthritis: one year follow-up outcomes","volume":"9","author":"Miyagawa","year":"2022","journal-title":"Front Med (Lausanne)"},{"issue":"6","key":"10.1016\/j.berh.2026.102129_bib49","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1002\/art.42803","article-title":"Modulation of Interleukin-23 signaling with Guselkumab in biologic-naive patients versus tumor necrosis factor inhibitor-inadequate responders with active psoriatic arthritis","volume":"76","author":"Siebert","year":"2024","journal-title":"Arthritis Rheumatol"},{"issue":"1","key":"10.1016\/j.berh.2026.102129_bib50","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1186\/s13075-023-03125-4","article-title":"Effect of guselkumab on serum biomarkers in patients with active psoriatic arthritis and inadequate response to tumor necrosis factor inhibitors: results from the COSMOS phase 3b study","volume":"25","author":"Schett","year":"2023","journal-title":"Arthritis Res Ther"},{"issue":"9","key":"10.1016\/j.berh.2026.102129_bib51","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1002\/art.42921","article-title":"Phase 2 trial of deucravacitinib in psoriatic arthritis: biomarkers associated with disease activity, pharmacodynamics, and clinical responses","volume":"76","author":"FitzGerald","year":"2024","journal-title":"Arthritis Rheumatol"},{"issue":"1","key":"10.1016\/j.berh.2026.102129_bib52","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1186\/s13075-022-02771-4","article-title":"Impact of serum interleukin-22 as a biomarker for the differential use of molecular targeted drugs in psoriatic arthritis: a retrospective study","volume":"24","author":"Miyagawa","year":"2022","journal-title":"Arthritis Res Ther"},{"issue":"9","key":"10.1016\/j.berh.2026.102129_bib53","first-page":"1847","article-title":"Synovial monocytes from psoriatic and rheumatoid arthritis patients are modulated differently by TNF inhibitors and glucocorticoids: an ex-vivo study","volume":"41","author":"Gertel","year":"2023","journal-title":"Clin Exp Rheumatol"},{"issue":"4","key":"10.1016\/j.berh.2026.102129_bib54","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1093\/rheumatology\/kez358","article-title":"Interleukin-36 family dysregulation drives joint inflammation and therapy response in psoriatic arthritis","volume":"59","author":"Boutet","year":"2020","journal-title":"Rheumatology (Oxford)"},{"issue":"4","key":"10.1016\/j.berh.2026.102129_bib55","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1080\/03009742.2019.1577490","article-title":"Hyaluronan concentration and molecular mass in psoriatic arthritis: biomarkers of disease severity, resistance to treatment, and outcome","volume":"48","author":"Hellman","year":"2019","journal-title":"Scand J Rheumatol"},{"key":"10.1016\/j.berh.2026.102129_bib56","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2025.1607312","article-title":"Leptin: a gender and obesity-related marker predictive of metabolic comorbidities and therapeutic response to anti-IL-23 biologic drugs in psoriatic patients","volume":"16","author":"Belli","year":"2025","journal-title":"Front Immunol"},{"issue":"6","key":"10.1016\/j.berh.2026.102129_bib57","doi-asserted-by":"crossref","first-page":"866","DOI":"10.3899\/jrheum.121162","article-title":"Soluble biomarkers associated with response to treatment with tumor necrosis factor inhibitors in psoriatic arthritis","volume":"40","author":"Chandran","year":"2013","journal-title":"J Rheumatol"},{"issue":"3","key":"10.1016\/j.berh.2026.102129_bib58","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1002\/acr.23298","article-title":"Differentiating psoriatic arthritis from psoriasis without psoriatic arthritis using novel serum biomarkers","volume":"70","author":"Cretu","year":"2018","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"1","key":"10.1016\/j.berh.2026.102129_bib59","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/s11306-023-02079-7","article-title":"Classifying patients with psoriatic arthritis according to their disease activity status using serum metabolites and machine learning","volume":"20","author":"Koussiouris","year":"2024","journal-title":"Metabolomics"},{"issue":"1","key":"10.1016\/j.berh.2026.102129_bib60","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1186\/s13075-024-03332-7","article-title":"Investigating protease-mediated peptides of inflammation and tissue remodeling as biomarkers associated with flares in psoriatic arthritis","volume":"26","author":"Groen","year":"2024","journal-title":"Arthritis Res Ther"},{"issue":"3","key":"10.1016\/j.berh.2026.102129_bib61","doi-asserted-by":"crossref","DOI":"10.1136\/rmdopen-2025-006019","article-title":"Serum calprotectin and complement factor C3 are superior biomarkers of inflammation in early psoriatic arthritis as compared with C-reactive protein","volume":"11","author":"Ishchenko","year":"2025","journal-title":"RMD Open"},{"issue":"3","key":"10.1016\/j.berh.2026.102129_bib62","doi-asserted-by":"crossref","first-page":"140","DOI":"10.55133\/eji.310314","article-title":"Serum calprotectin as an inflammatory marker in psoriatic arthritis patients: relation to disease activity and musculoskeletal ultrasound findings","volume":"31","author":"Hamada","year":"2024","journal-title":"Egypt J Immunol"},{"issue":"1","key":"10.1016\/j.berh.2026.102129_bib63","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1080\/03009742.2025.2523667","article-title":"Calprotectin (S100A8\/A9) is not associated with ultrasound-detected synovitis in a longitudinal study of patients with psoriatic arthritis treated with biological disease-modifying anti-rheumatic drugs","volume":"55","author":"Roym","year":"2026","journal-title":"Scand J Rheumatol"},{"issue":"12","key":"10.1016\/j.berh.2026.102129_bib64","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.3899\/jrheum.2024-0396","article-title":"Candidate biomarkers for response to treatment in psoriatic disease","volume":"51","author":"Offenheim","year":"2024","journal-title":"J Rheumatol"},{"issue":"3","key":"10.1016\/j.berh.2026.102129_bib65","doi-asserted-by":"crossref","first-page":"380","DOI":"10.31138\/mjr.151024.mpr","article-title":"Matrix Metalloproteinase-9 as a biomarker for diagnosis and monitor disease progression in psoriatic arthritis","volume":"36","author":"Prisila","year":"2025","journal-title":"Mediterr J Rheumatol"},{"issue":"1","key":"10.1016\/j.berh.2026.102129_bib66","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1186\/s12967-025-06174-2","article-title":"Wnt signaling as a translational target in rheumatoid and psoriatic arthritis","volume":"23","author":"Riitano","year":"2025","journal-title":"J Transl Med"},{"issue":"1","key":"10.1016\/j.berh.2026.102129_bib67","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-025-98395-0","article-title":"Serum extracellular matrix biomarkers in rheumatoid arthritis, psoriatic arthritis and psoriasis and their association with hand function","volume":"15","author":"Port","year":"2025","journal-title":"Sci Rep"},{"issue":"11","key":"10.1016\/j.berh.2026.102129_bib68","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1007\/s00296-025-06012-0","article-title":"Axial spondyloarthritis, psoriatic arthritis and systemic lupus erythematosus share common molecular features based on post-hoc analysis of serum biomarkers","volume":"45","author":"Malmkvist","year":"2025","journal-title":"Rheumatol Int"},{"key":"10.1016\/j.berh.2026.102129_bib69","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1355824","article-title":"Increased interleukin-26 in the peripheral joints of patients with axial spondyloarthritis and psoriatic arthritis, co-localizing with CD68-positive synoviocytes","volume":"15","author":"Hammitzsch","year":"2024","journal-title":"Front Immunol"},{"issue":"1","key":"10.1016\/j.berh.2026.102129_bib70","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/s10238-025-01952-0","article-title":"Modulation of cellular senescence in psoriatic arthritis: exploring the potential impact of bDMARDs on telomere length, mtDNA copy number, and oxidative damage","volume":"26","author":"De Benedittis","year":"2025","journal-title":"Clin Exp Med"},{"issue":"5","key":"10.1016\/j.berh.2026.102129_bib71","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1111\/bjd.18940","article-title":"Declining levels of serum chemokine (C-X-C motif) ligand 10 over time are associated with new onset of psoriatic arthritis in patients with psoriasis: a new biomarker?","volume":"183","author":"Abji","year":"2020","journal-title":"Br J Dermatol"},{"issue":"15","key":"10.1016\/j.berh.2026.102129_bib72","doi-asserted-by":"crossref","DOI":"10.1172\/JCI186135","article-title":"CXCL10 secreted by SPRY1-deficient epidermal keratinocytes fuels joint inflammation in psoriatic arthritis via CD14 signaling","volume":"135","author":"Xu","year":"2025","journal-title":"J Clin Investig"},{"issue":"3","key":"10.1016\/j.berh.2026.102129_bib73","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.ejr.2021.11.006","article-title":"Role of musculoskeletal ultrasound, magnetic resonance imaging, and serum chemokine C-X-C motif ligand 10 in early detection of arthritis in patients with psoriasis","volume":"44","author":"Soliman","year":"2022","journal-title":"Egyptian Rheumatol"},{"issue":"6","key":"10.1016\/j.berh.2026.102129_bib74","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1002\/art.42661","article-title":"Derivation of a multivariable psoriatic arthritis risk estimation tool (PRESTO): a step towards prevention","volume":"77","author":"Eder","year":"2025","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.berh.2026.102129_bib75","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1497713","article-title":"Psoriatic arthritis in psoriasis: optimizing the current screening system for psoriatic arthritis based on serum data from U.S. and Chinese populations","volume":"15","author":"Lin","year":"2024","journal-title":"Front Immunol"},{"issue":"11","key":"10.1016\/j.berh.2026.102129_bib76","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1002\/acr.25539","article-title":"Association of higher levels of high-sensitivity C-Reactive protein with future development of psoriatic arthritis in psoriasis: a prospective cohort Study","volume":"77","author":"Eder","year":"2025","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"10.1016\/j.berh.2026.102129_bib77","doi-asserted-by":"crossref","first-page":"3213","DOI":"10.2147\/CCID.S552493","article-title":"Evaluation of pan-immune-inflammation value (PIV) as a predictive biomarker for psoriatic arthritis in patients with psoriasis","volume":"18","author":"Koc Babayigit","year":"2025","journal-title":"Clin Cosmet Invest Dermatol"},{"issue":"2","key":"10.1016\/j.berh.2026.102129_bib78","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1002\/art.41239","article-title":"Association of structural entheseal lesions with an increased risk of progression from psoriasis to psoriatic arthritis","volume":"74","author":"Simon","year":"2022","journal-title":"Arthritis Rheumatol"},{"issue":"1","key":"10.1016\/j.berh.2026.102129_bib79","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1109\/JBHI.2024.3487785","article-title":"Novel digital biomarkers for fine motor skills assessment in psoriatic arthritis: the DaktylAct touch-based serious game approach","volume":"29","author":"Vasileiou","year":"2025","journal-title":"IEEE J Biomed Health Inform"},{"issue":"1","key":"10.1016\/j.berh.2026.102129_bib80","doi-asserted-by":"crossref","first-page":"e29","DOI":"10.1017\/S0266462325000091","article-title":"Identifying characteristics for a cost-effective psoriatic arthritis biomarker test: a development-focused health technology assessment","volume":"41","author":"Tam","year":"2025","journal-title":"Int J Technol Assess Health Care"},{"issue":"3","key":"10.1016\/j.berh.2026.102129_bib81","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1038\/s41584-022-00748-w","article-title":"HIPPOCRATES: improving diagnosis and outcomes in psoriatic arthritis","volume":"18","author":"FitzGerald","year":"2022","journal-title":"Nat Rev Rheumatol"},{"issue":"12","key":"10.1016\/j.berh.2026.102129_bib82","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2022-063650","article-title":"Efficacy of guselkumab, a selective IL-23 inhibitor, in Preventing Arthritis in a Multicentre Psoriasis At-Risk cohort (PAMPA): protocol of a randomised, double-blind, placebo controlled multicentre trial","volume":"12","author":"Haberman","year":"2022","journal-title":"BMJ Open"}],"container-title":["Best Practice & Research Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521694226000148?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521694226000148?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T07:39:20Z","timestamp":1789112360000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521694226000148"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":82,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["S1521694226000148"],"URL":"https:\/\/doi.org\/10.1016\/j.berh.2026.102129","relation":{},"ISSN":["1521-6942"],"issn-type":[{"value":"1521-6942","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The promise of biomarkers in Psoriatic Arthritis: Moving towards precision medicine","name":"articletitle","label":"Article Title"},{"value":"Best Practice & Research Clinical Rheumatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.berh.2026.102129","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"102129"}}